Fate Therapeutics (FATE) Current Assets (2016 - 2025)
Historic Current Assets for Fate Therapeutics (FATE) over the last 14 years, with Q3 2025 value amounting to $221.3 million.
- Fate Therapeutics' Current Assets fell 2869.63% to $221.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $221.3 million, marking a year-over-year decrease of 2869.63%. This contributed to the annual value of $291.9 million for FY2024, which is 1195.36% down from last year.
- According to the latest figures from Q3 2025, Fate Therapeutics' Current Assets is $221.3 million, which was down 2869.63% from $230.4 million recorded in Q2 2025.
- Fate Therapeutics' Current Assets' 5-year high stood at $804.3 million during Q1 2021, with a 5-year trough of $221.3 million in Q3 2025.
- Its 5-year average for Current Assets is $453.8 million, with a median of $394.4 million in 2024.
- Per our database at Business Quant, Fate Therapeutics' Current Assets surged by 28622.8% in 2021 and then tumbled by 3706.07% in 2025.
- Quarter analysis of 5 years shows Fate Therapeutics' Current Assets stood at $633.4 million in 2021, then fell by 20.74% to $502.1 million in 2022, then plummeted by 33.97% to $331.5 million in 2023, then decreased by 11.95% to $291.9 million in 2024, then decreased by 24.21% to $221.3 million in 2025.
- Its Current Assets stands at $221.3 million for Q3 2025, versus $230.4 million for Q2 2025 and $248.2 million for Q1 2025.